Publications

December 2021

Characterization of a patient-derived variant of GPX4 for precision therapy

October 2021

Use of Nonclinical and Expanded Access Clinical Study data to Guide Development Programs Targeting Mitochondrial Diseases of Lipid Peroxidation

June 2021

RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations

May 2021

Toward Quantitative Sequencing of Deuteration of Unsaturated Hydrocarbon Chains in Fatty Acids

December 2020

Isotope-reinforced polyunsaturated fatty acids improve Parkinson’s disease-like phenotype in rats overexpressing α-synuclein

September 2020

Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001

August 2020

The infantile neuroaxonal dystrophy rating scale (INAD-RS).

April 2020

Site-specifically deuterated essential lipids

April 2020

Alpha synuclein aggregation drives ferroptosis

March 2020

Treatment of infantile neuroaxonal dystrophy with RT001

March 2020

The natural history of infantile neuroaxonal dystrophy.

March 2020

Polyunsaturated Fatty Acid Deuteration against Neurodegeneration

May 2019

Deuterated Polyunsaturated Fatty Acids Reduce Oxidative Stress and Extend the Lifespan of C. elegans

May 2019

RT001 to treat neurodegeneration—Case Study: Improvement in a single patient with Late Onset Tay-Sachs Disease (LOTS)

March 2019

Threshold Protective Effect of Deuterated Polyunsaturated Fatty Acids on Peroxidation of Lipid Bilayers